LifeVest by Zoll is the first and only wearable defibrillator. The LifeVest® wearable defibrillator is a new treatment option for sudden cardiac arrest. It offers you or your loved one constant monitoring, immediate protection, and peace of mind. +++ LifeVest Wearable Defibrillator: The LifeVest is the first wearable defibrillator. Unlike an implantable cardioverter defibrillator (ICD), the LifeVest is worn outside the body rather than implanted in the chest. This device continuously monitors the patient's heart with dry, non-adhesive sensing electrodes to detect life-threatening abnormal heart rhythms. If a life-threatening rhythm is detected, the device alerts the patient prior to delivering a shock, and thus allows a conscious patient to disarm the shock. If you or your loved one is unconscious, the device releases a gel over the therapy electrodes and delivers an electrical shock to restore normal rhythm. +++++++ Key Benefits: ^^^^^ Constant Monitoring = * Records critical user data to help diagnose and treat arrhythmic conditions. * Provides continuous ECG and user compliance monitoring. ^^^^^ Immediate Protection = * Advanced VT/VF detection algorithm tailored to the user. * Fully-automated system that offers less-than-one-minute treatment for unresponsive patients suffering from a tachyarrhythmia. ^^^^^ Peace of Mind = * Protects you or your loved one while determining the need for an ICD. * Fully automatic--doesn’t require bystander response or intervention from anyone. * Lightweight device allows freedom of movement and a return to normal activities. Zoll mfrg. data provides a rationale for considering early interventional strategies, including short-term therapies, in selected users at risk: ### Solomon SD et al. “Sudden Death in Patients with Myocardial Infarction and Left Ventricular Dysfunction, Heart Failure, or Both.” NEJM 2005; 352:2581-2588. ### “An alternative solution [to immediately implanting an ICD], given the observance that risk drops dramatically within six months after acute myocardial infarction, might be to provide noninvasive vest defibrillators…to high-risk users for limited periods.” ### Buxton AE. “Sudden Death after Myocardial Infarction–Who Needs Prophylaxis, and When?” NEJM 2005; 352:2638-2640. ******* THIS IS A SPECIAL ORDER ITEM AND REQUIRES A LICENSED PRACTITIONERS MEDICAL PRESCRIPTION ORDER. *******